following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)...
schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals.".
marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
``much of this delay in implementation can be attributed to the lack of coordination and cooperation between the city and county.''. my profile.